YU134790A - Plazmidi, njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora - Google Patents

Plazmidi, njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora

Info

Publication number
YU134790A
YU134790A YU134790A YU134790A YU134790A YU 134790 A YU134790 A YU 134790A YU 134790 A YU134790 A YU 134790A YU 134790 A YU134790 A YU 134790A YU 134790 A YU134790 A YU 134790A
Authority
YU
Yugoslavia
Prior art keywords
plasmids
rscu
protein
synthetic
unglycosylated
Prior art date
Application number
YU134790A
Other languages
English (en)
Other versions
YU48371B (sh
Inventor
R.E. Brigelus-Flohe
L. Flohe
W. Hillen
G.J. Steffens
W. Strassburger
M.R.F. Wilhelm
Original Assignee
Gruenenthal Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh. filed Critical Gruenenthal Gmbh.
Priority to SI9011347A priority Critical patent/SI9011347B/sl
Priority to HRP-1347/90A priority patent/HRP920596B1/xx
Publication of YU134790A publication Critical patent/YU134790A/sh
Publication of YU48371B publication Critical patent/YU48371B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PLAZMIDI, NJIHOVO DOBIJANJE I NJIHOVA UPOTREBA PRI DOBIJANJU JEDNOG PLAZMINOGENAKTIVATORA. Opisani su plazmidi sa sintetskim DNK sekvencama, koji su pogodni da eksprimiraju jedan protein prvog stupnja rscu PA (naime neglikoliziranog dela proteina jednolančane prourinokinaze) u Enterobacteriaceen, nročito E.coli, u količini koja je znatno iznad one koja se nalazi pri upotrebi plazmida prema stanju tehnike. Plazmidi prema pronalasku se karakterišu time što njihov operon ima jedan promotor koji se može regulisati, u datom slučaju sintetski promotor, jednu Shine Delgrano sekvencu, jedan startni kodon, jedan startnikodon, jedan sintetski strukturni gen i na niže od strukturnog gena najmanje jedan terminator. Dobijanje plazmida kao i sintetskih DNK sekvenci polazeći od komercijalnih plazmida itd je opisano. Pri njihovoj upotrebiu pri visokim brzinama eksprimiran protein prvog stupnja rscu PA može se na poznat način ponovo nabrati u terapeutski primenljiv rscu PA kao plazminogenaktivator, koji se tad prema želji može na poznat način cepati radi dobijanja dvolančanog proteina urokinaze (rtcu-PA) i primeniti u tehničkom obimu.
YU134790A 1989-07-19 1990-07-11 Plazmidi njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora YU48371B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9011347A SI9011347B (sl) 1989-07-19 1990-07-11 Plazmidi, njihova priprava in njihova uporaba pri pridobivanju plazminogenskega aktivatorja
HRP-1347/90A HRP920596B1 (en) 1989-07-19 1992-09-29 Plasmides, the production thereof and their use in producing one plasminogen activator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3923866 1989-07-19

Publications (2)

Publication Number Publication Date
YU134790A true YU134790A (sh) 1992-12-21
YU48371B YU48371B (sh) 1998-07-10

Family

ID=6385369

Family Applications (1)

Application Number Title Priority Date Filing Date
YU134790A YU48371B (sh) 1989-07-19 1990-07-11 Plazmidi njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora

Country Status (30)

Country Link
US (1) US5637503A (sh)
EP (1) EP0408945B1 (sh)
JP (1) JP3236284B2 (sh)
KR (1) KR0167761B1 (sh)
AT (1) ATE131534T1 (sh)
AU (1) AU631662B2 (sh)
CA (1) CA2020656C (sh)
DD (1) DD298426A5 (sh)
DE (2) DE4020438A1 (sh)
DK (1) DK0408945T3 (sh)
ES (1) ES2083399T3 (sh)
FI (1) FI102386B (sh)
GR (1) GR3019294T3 (sh)
HK (1) HK1005193A1 (sh)
HR (1) HRP920596B1 (sh)
HU (1) HU214243B (sh)
IE (1) IE901849A1 (sh)
IL (1) IL94529A (sh)
LT (1) LT3611B (sh)
LV (1) LV10120B (sh)
MT (1) MTP1063B (sh)
NO (1) NO304952B1 (sh)
NZ (1) NZ234542A (sh)
PL (1) PL166199B1 (sh)
PT (1) PT94776B (sh)
RU (1) RU2073720C1 (sh)
SI (1) SI9011347B (sh)
SK (1) SK280028B6 (sh)
YU (1) YU48371B (sh)
ZA (1) ZA904006B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2067226A1 (sh) * 1969-11-27 1971-08-20 Cefilac
DE4101736A1 (de) * 1991-01-22 1992-07-23 Gruenenthal Gmbh Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
KR100467034B1 (ko) * 1996-12-27 2006-04-07 주식회사 엘지생활건강 압축성형타입오일케익화장료및그의제조방법
KR100372233B1 (ko) * 1997-03-12 2003-06-11 주식회사 코리아나화장품 미백 파우더, 그의 제조방법 및 그를 함유하는 메이크업 미백 화장료
KR100341638B1 (ko) * 2000-03-17 2002-06-22 유상옥,송운한 기능성 표면처리 분체의 제조 방법 및 이를 함유하는메이크업 화장료 조성물
JP4124639B2 (ja) * 2002-12-17 2008-07-23 株式会社日本触媒 大腸菌を用いたｓ−ヒドロキシニトリルリアーゼの製造方法
US7906276B2 (en) * 2004-06-30 2011-03-15 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
UA100692C2 (ru) 2007-05-02 2013-01-25 Мериал Лимитед Днк-плазмиды, имеющие повышенную экспрессию и стабильность
RU2553533C2 (ru) * 2013-10-23 2015-06-20 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") Способ выделения и очистки рекомбинантной человеческой проурокиназы м5
CN104555732A (zh) * 2015-01-18 2015-04-29 河南省中原起重机械总厂 一种多功能门式起重机

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
FI88932C (fi) * 1982-04-15 1993-07-26 Genentech Inc Framstaellning av funktionellt maenskligt urokinasprotein
US4710464A (en) * 1984-09-27 1987-12-01 Eli Lilly And Company Transcription terminators
DE3680838D1 (de) * 1985-01-25 1991-09-19 Sagami Chem Res Stabilisierte menschliche prourokinase.
FR2594845B1 (fr) * 1986-02-21 1989-12-01 Genetica Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
HU208712B (en) * 1987-08-10 1993-12-28 Lepetit Spa Method for preparing single or double strained glycolised human urokinase and pharmaceutical composition comprising same
EP0372005A4 (en) * 1987-10-30 1990-06-26 Oncogen EXPRESSION SYSTEMS FOR THE PREPARATION OF POLYPEPTIDES IN PROKARYOTIC CELLS.

Also Published As

Publication number Publication date
HK1005193A1 (en) 1998-12-24
LV10120A (lv) 1994-05-10
EP0408945A1 (de) 1991-01-23
DK0408945T3 (da) 1996-04-09
DD298426A5 (de) 1992-02-20
CA2020656C (en) 2001-05-22
ES2083399T3 (es) 1996-04-16
HRP920596A2 (en) 1998-06-30
HU903970D0 (en) 1990-11-28
HUT54211A (en) 1991-01-28
YU48371B (sh) 1998-07-10
ZA904006B (en) 1991-03-27
EP0408945B1 (de) 1995-12-13
IE901849A1 (en) 1991-06-19
PL166199B1 (pl) 1995-04-28
PT94776B (pt) 1997-09-30
KR0167761B1 (ko) 1999-01-15
SK306790A3 (en) 1999-07-12
LT3611B (en) 1995-12-27
KR910003105A (ko) 1991-02-26
RU2073720C1 (ru) 1997-02-20
FI102386B1 (fi) 1998-11-30
PL286087A1 (en) 1991-03-11
SK280028B6 (sk) 1999-07-12
NO902720L (no) 1991-01-21
CA2020656A1 (en) 1991-01-20
NO304952B1 (no) 1999-03-08
HRP920596B1 (en) 1999-12-31
US5637503A (en) 1997-06-10
PT94776A (pt) 1991-03-20
SI9011347A (sl) 1998-04-30
LTIP776A (en) 1995-01-31
LV10120B (en) 1994-10-20
GR3019294T3 (en) 1996-06-30
FI102386B (fi) 1998-11-30
IL94529A0 (en) 1991-03-10
AU631662B2 (en) 1992-12-03
IL94529A (en) 1997-11-20
HU214243B (hu) 1998-03-02
DE4020438A1 (de) 1991-01-31
NZ234542A (en) 1991-09-25
MTP1063B (en) 1991-04-08
FI903640A0 (fi) 1990-07-18
NO902720D0 (no) 1990-06-19
DE59009961D1 (de) 1996-01-25
AU5883290A (en) 1991-01-24
ATE131534T1 (de) 1995-12-15
JPH0365189A (ja) 1991-03-20
SI9011347B (sl) 1999-02-28
JP3236284B2 (ja) 2001-12-10

Similar Documents

Publication Publication Date Title
YU134790A (sh) Plazmidi, njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora
DK348986A (da) Fremgangsmaade til forstaerkning af ekspressionen af rekombinant dna-produkter
LIBBY et al. Expression and purification of native human granulocyte-macrophage colony-stimulating factor from an Escherichia coli secretion vector
JP3920331B2 (ja) 細菌において細胞外タンパク質を製造するための方法
AU579991B2 (en) Nucleic acids, plasmids containing such acids, processes for their preparation and the use of such plasmids in the synthesis of gene products
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
Konrad Applications of genetic engineering to the pharmaceutical industry.